These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 25726084)
1. Overexpression of survivin via activation of ERK1/2, Akt, and NF-κB plays a central role in vincristine resistance in multiple myeloma cells. Tsubaki M; Takeda T; Ogawa N; Sakamoto K; Shimaoka H; Fujita A; Itoh T; Imano M; Ishizaka T; Satou T; Nishida S Leuk Res; 2015 Apr; 39(4):445-52. PubMed ID: 25726084 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of MDR1 and survivin, and decreased Bim expression mediate multidrug-resistance in multiple myeloma cells. Tsubaki M; Satou T; Itoh T; Imano M; Komai M; Nishinobo M; Yamashita M; Yanae M; Yamazoe Y; Nishida S Leuk Res; 2012 Oct; 36(10):1315-22. PubMed ID: 22819074 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of HIF-1α contributes to melphalan resistance in multiple myeloma cells by activation of ERK1/2, Akt, and NF-κB. Tsubaki M; Takeda T; Tomonari Y; Koumoto YI; Imano M; Satou T; Nishida S Lab Invest; 2019 Jan; 99(1):72-84. PubMed ID: 30353128 [TBL] [Abstract][Full Text] [Related]
4. Bim downregulation by activation of NF-κB p65, Akt, and ERK1/2 is associated with adriamycin and dexamethasone resistance in multiple myeloma cells. Tsubaki M; Takeda T; Matsuda T; Kishimoto K; Tanaka R; Tsurushima K; Ishizaka T; Nishida S Clin Exp Med; 2023 Sep; 23(5):1597-1607. PubMed ID: 36451049 [TBL] [Abstract][Full Text] [Related]
5. Perifosine downregulates MDR1 gene expression and reverses multidrug-resistant phenotype by inhibiting PI3K/Akt/NF-κB signaling pathway in a human breast cancer cell line. Lin X; Zhang X; Wang Q; Li J; Zhang P; Zhao M; Li X Neoplasma; 2012; 59(3):248-56. PubMed ID: 22329846 [TBL] [Abstract][Full Text] [Related]
6. By inhibiting Src, verapamil and dasatinib overcome multidrug resistance via increased expression of Bim and decreased expressions of MDR1 and survivin in human multidrug-resistant myeloma cells. Tsubaki M; Komai M; Itoh T; Imano M; Sakamoto K; Shimaoka H; Takeda T; Ogawa N; Mashimo K; Fujiwara D; Mukai J; Sakaguchi K; Satou T; Nishida S Leuk Res; 2014 Jan; 38(1):121-30. PubMed ID: 24239173 [TBL] [Abstract][Full Text] [Related]
7. COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer. Sui H; Zhou S; Wang Y; Liu X; Zhou L; Yin P; Fan Z; Li Q Carcinogenesis; 2011 May; 32(5):667-75. PubMed ID: 21296766 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronan oligosaccharides sensitize lymphoma resistant cell lines to vincristine by modulating P-glycoprotein activity and PI3K/Akt pathway. Cordo Russo RI; García MG; Alaniz L; Blanco G; Alvarez E; Hajos SE Int J Cancer; 2008 Mar; 122(5):1012-8. PubMed ID: 17985348 [TBL] [Abstract][Full Text] [Related]
9. The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism. Chiarini F; Del Sole M; Mongiorgi S; Gaboardi GC; Cappellini A; Mantovani I; Follo MY; McCubrey JA; Martelli AM Leukemia; 2008 Jun; 22(6):1106-16. PubMed ID: 18385752 [TBL] [Abstract][Full Text] [Related]
10. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer. Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223 [TBL] [Abstract][Full Text] [Related]
11. Increased 14-3-3ζ expression in the multidrug-resistant leukemia cell line HL-60/VCR as compared to the parental line mediates cell growth and apoptosis in part through modification of gene expression. Liang R; Chen XQ; Bai QX; Wang Z; Zhang T; Yang L; Dong BX; Gao GX; Gu HT; Zhu HF Acta Haematol; 2014; 132(2):177-86. PubMed ID: 24603438 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA H19 promotes vincristine resistance in multiple myeloma by targeting Akt. Wang Y; Xu S; Wang L; Liu J; Wang J; Zhou J Cell Mol Biol (Noisy-le-grand); 2020 Sep; 66(6):76-80. PubMed ID: 33040789 [TBL] [Abstract][Full Text] [Related]
13. cIAP-2 protects cardiac fibroblasts from oxidative damage: an obligate regulatory role for ERK1/2 MAPK and NF-κB. Philip L; Shivakumar K J Mol Cell Cardiol; 2013 Sep; 62():217-26. PubMed ID: 23837962 [TBL] [Abstract][Full Text] [Related]
14. BRCA1-IRIS overexpression promotes cisplatin resistance in ovarian cancer cells. Chock KL; Allison JM; Shimizu Y; ElShamy WM Cancer Res; 2010 Nov; 70(21):8782-91. PubMed ID: 20940403 [TBL] [Abstract][Full Text] [Related]
15. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR. Yang YX; Xiao ZQ; Chen ZC; Zhang GY; Yi H; Zhang PF; Li JL; Zhu G Proteomics; 2006 Mar; 6(6):2009-21. PubMed ID: 16525997 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine. Xie X; Tang B; Zhou J; Gao Q; Zhang P Oncol Rep; 2013 Aug; 30(2):773-82. PubMed ID: 23743572 [TBL] [Abstract][Full Text] [Related]
17. Reversal effect of Raf-1/Mdr-1 siRNAs co-transfection on multidrug resistance in KBv200 cell line. Dong Y; Shao S; Hu J; Yang P Oral Oncol; 2009 Nov; 45(11):991-7. PubMed ID: 19631573 [TBL] [Abstract][Full Text] [Related]
18. [Wnt5a modulates vincristine resistance through PI3K/Akt/GSK3β signaling pathway in human ovarian carcinoma SKOV3/VCR cells]. Wu FL; Chen HL; Hu XW; Liang LY; Xu WL Sheng Li Xue Bao; 2019 Jun; 71(3):415-423. PubMed ID: 31218332 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides. Cucco C; Calabretta B Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118 [TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein and survivin simultaneously regulate vincristine-induced apoptosis in chronic myeloid leukemia cells. Souza PS; Vasconcelos FC; De Souza Reis FR; Nestal De Moraes G; Maia RC Int J Oncol; 2011 Oct; 39(4):925-33. PubMed ID: 21720708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]